Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02500550
Brief Title: Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

First Submitted : July 14, 2015
First Submitted that Met QC Criteria : July 14, 2015
First Posted : July 16, 2015 (Estimate)

Certification/Extension First Submitted : August 19, 2019
Certification/Extension First Submitted that Met QC Criteria : August 19, 2019
Certification/Extension First Posted : August 20, 2019

Last Update Submitted that Met QC Criteria : April 2, 2020
Last Update Posted : April 8, 2020